{"filing":{"accession_number":"0001683168-26-005555","cik":"0001355790","ticker":"ISCO","company_name":"International Stem Cell CORP","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"intlstemcell_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1355790/000168316826005555/intlstemcell_8k.htm"},"events":[{"id":18242,"run_id":16392,"accession_number":"0001683168-26-005555","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"International Stem Cell Corporation entered into a Membership Interest Purchase Agreement on July 10, 2026, to sell 100% of Lifeline Cell Technology, LLC to American Type Culture Collection, Inc. for $25.0 million. This is a material disposition of a subsidiary representing a significant asset sale, with customary closing conditions and stockholder approval requirements, clearly constituting a material M\u0026A transaction under Item 1.01.","company_name":"International Stem Cell CORP","ticker":"ISCO","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16994,"accession_number":"0001683168-26-005555","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"International Stem Cell Corporation entered into a Membership Interest Purchase Agreement on July 10, 2026, to sell 100% of Lifeline Cell Technology, LLC to American Type Culture Collection, Inc. for $25.0 million. This is a material disposition of a subsidiary representing a significant asset sale, with customary closing conditions and stockholder approval requirements, clearly constituting a material M\u0026A transaction under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:04:24.461085+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16994,"accession_number":"0001683168-26-005555","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"International Stem Cell Corporation entered into a Membership Interest Purchase Agreement on July 10, 2026, to sell 100% of Lifeline Cell Technology, LLC to American Type Culture Collection, Inc. for $25.0 million. This is a material disposition of a subsidiary representing a significant asset sale, with customary closing conditions and stockholder approval requirements, clearly constituting a material M\u0026A transaction under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:04:24.461085+00:00","company_name":"International Stem Cell CORP","ticker":"ISCO","filing_date":"2026-07-15"}]}